经香港联交所批准，公司本次发行的108,619,000股H股股票（行使超额配售权之前）于2025年11月5日 在香港联交所主板挂牌并上市交易。公司H股股票中文简称为"赛力斯"，英文简称为"SERES"，股份代 号为"9927"。 格隆汇11月5日丨赛力斯(601127.SH)公布，公司本次全球发售H股总数为108,619,000股（行使超额配售 权之前），其中，香港公开发售10,861,900股，约占全球发售总数的10.00%（行使超额配售权之前）； 国际发售97,757,100股，约占全球发售总数的90.00%（行使超额配售权之前）。根据每股H股发售价 131.50港元计算，经扣除全球发售相关承销佣金及其他估计费用后，并假设超额配售权未获行使，公司 将收取的全球发售所得款项净额估计约为140.16亿港元。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、完整、及时，没有虚假记 载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，大明电子股份有限公司（以下简称"大明电子"或"公司"）发行的人民币普 通股股票将于２０２５年１１月６日在上海证券交易所主板上市，上市公告书全文和首次公开发行股票 的招股说明书全文披露于上海证券交易所网站（ｗｗｗ．ｓｓｅ．ｃｏｍ．ｃｎ）和符合中国证监会规 定条件网站（中证网，网址ｗｗｗ．ｃｓ．ｃｏｍ．ｃｎ；中国证券网，网址 ｗｗｗ．ｃｎｓｔｏｃ ｋ．ｃｏｍ；证券时报网，网址ｗｗｗ．ｓｔｃｎ．ｃｏｍ；证券日报网，网址ｗｗｗ．ｚｑｒｂ．ｃ ｎ；经济参考网，网址ｗｗｗ．ｊｊｃｋｂ．ｃｎ；中国金融新闻网，网址ｗｗｗ．ｆｉｎａｎｃｉａ ｌｎｅｗｓ．ｃｏｍ．ｃｎ；中国日报网，网址ｃｎ．ｃｈｉｎａｄａｉｌｙ．ｃｏｍ．ｃｎ），供投 资者查阅。 本公司提醒广大投资者注意首次公开发行股票（以下简称"新股"）上市初期的投资风险，提醒投资者充 分了解交易风险、理性参与新股交易，具体如下： （一）涨跌幅限制放宽带来的股票交易风险 根据《上海证券交 ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. ...

Core Viewpoint - Cambridge Technology Co., Ltd. (剑桥科技) successfully listed on the Hong Kong Stock Exchange, closing at HKD 92.20, a 33.86% increase from its final offering price of HKD 68.88 [1][5]. Summary by Relevant Sections IPO Details - The total number of H-shares issued under the global offering is 67,010,500, with 6,701,050 shares allocated for the Hong Kong offering and 60,309,450 shares for international offering [1]. - The total proceeds from the offering amount to HKD 4,615.7 million, with net proceeds of HKD 4,480.0 million after deducting estimated listing expenses of HKD 135.7 million [5]. Use of Proceeds - Approximately 50% (HKD 2,240.0 million) of the net proceeds will be used to enhance the company's facilities and the capacity of current and future co-location partners [5]. - About 20% (HKD 896.0 million) will be allocated to further enhance R&D talent and technology [5]. - 5% (HKD 224.0 million) will be used for business promotion and marketing [5]. - 15% (HKD 672.0 million) is earmarked for overseas strategic investments [5]. - 10% (HKD 448.0 million) will be used for general corporate purposes, including working capital needs [5]. Key Investors - Major cornerstone investors include Baillie Gifford, Morgan Stanley Investment Partners, HCEP, and several others, with significant allocations of shares [3][4]. - Notable allocations include 3.37% for Baillie Gifford, Morgan Stanley, and HCEP, and 5.06% for Qidian Asset Management [4]. Company Overview - Cambridge Technology primarily engages in the design, development, and sale of connectivity and data transmission equipment, generating revenue mainly from broadband, wireless, and optical module technology products [6]. - The company is recognized as one of the few that provides all three types of technology products to global customers [6].

超颖电子电路股份有限公司 首次公开发行股票主板 上市公告书提示性公告 保荐人（主承销商）： 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准 确、完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，超颖电子电路股份有限公司（以下简称"本公 司"、"发行人"、"公司"、"超颖电子"）发行的人民币普通股股票将于 2025 年 10 月 24 日在上海证券交易所主板上市，上市公告书全文和首次公开发行股票 的招股说明书全文披露于上海证券交易所网站（http://www.sse.com.cn/）和符合 中国证监会规定条件网站（中证网：http://www.cs.com.cn；上海证券报网： http://www.cnstock.com；证券时报网：http://www.stcn.com；证券日报网： http://www.zqrb.cn；经济参考网：http://www.jjckb.cn；中国金融新闻网： https://www.financialnews.com.cn；中国日报网：https://cn.chinadaily.com.cn）披 露，并置备于发 ...

Core Viewpoint - Marco Polo announced that its stock will be listed on the Shenzhen Stock Exchange main board on October 22, 2025, under the stock name "Marco Polo" with the code 001386 [1] Summary by Relevant Sections - **Initial Public Offering (IPO) Details** - Total share capital after the IPO will be 1.195 billion shares, with 119 million shares being issued [1] - **Investor Warnings** - The company cautions investors about several risks, including the potential for increased volatility due to the lifting of price limits, the stock being eligible for margin trading on the first day of listing, a low number of circulating shares, speculative trading, differences in the issuance price-to-earnings ratio compared to industry peers, the possibility of the stock price falling below the issuance price, and a decline in return on equity [1]

Core Viewpoint - Jebang Technology (301326.SZ) reported a revenue of 438 million yuan for the first half of 2023, marking a year-on-year increase of 27.51%, but faced significant net losses [1][2]. Financial Performance - The company's revenue for the first half of 2023 was 437,563,581.36 yuan, up 27.51% from 343,161,782.76 yuan in the same period last year [2]. - The net profit attributable to shareholders was -38,023,569.68 yuan, a decline of 572.70% compared to -5,652,381.96 yuan in the previous year [2]. - The net profit after deducting non-recurring gains and losses was -42,653,207.11 yuan, representing a decrease of 195.19% from -14,449,608.02 yuan [2]. - The net cash flow from operating activities was -65,423,440.64 yuan, a drop of 537.21% from -10,267,235.33 yuan [2]. Future Projections - For 2024, the company is projected to achieve a revenue of 792,805,238.89 yuan, a 16.90% increase from 678,193,574.22 yuan in 2023 [3]. - The net profit attributable to shareholders is expected to improve to -19,348,460.60 yuan, a 65.33% reduction from -55,803,415.39 yuan in 2023 [3]. - The net profit after deducting non-recurring gains and losses is projected to be -33,129,566.38 yuan, a 53.10% improvement from -70,641,707.56 yuan [3]. - The net cash flow from operating activities is anticipated to be 20,799,161.98 yuan, a significant decrease of 85.85% from 146,987,913.70 yuan in 2023 [3]. IPO and Fundraising - Jebang Technology raised a total of 936.132 million yuan from its initial public offering, with a net amount of 836.9503 million yuan after deducting issuance costs [4]. - The final net fundraising amount exceeded the original plan by 28.69503 million yuan [4]. - The funds are intended for the construction of a high-precision electronic functional structural component production base, a research and development center, and to supplement working capital [4].

Core Viewpoint - AstraZeneca plans to switch to a direct listing of its shares in the United States to capitalize on the booming U.S. stock market [1] Group 1: Company Strategy - The company aims to maximize gains from the U.S. stock market through this direct listing approach [1]

Core Viewpoint - Zhenlei Technology (688270.SH) announced that its chairman, Yu Faxin, is currently under investigation by the Huangshi Municipal Supervisory Committee, but the company's control has not changed and normal operations will continue [1] Group 1: Company Governance and Management - The company has a robust governance structure and internal control mechanisms in place, ensuring that daily operations are managed by senior management during the chairman's absence [1] - Zhang Bing, a board member, will temporarily assume the chairman's responsibilities while Yu Faxin is unable to perform his duties [1] Group 2: Financial Performance - In the first half of 2025, Zhenlei Technology achieved a revenue of 205 million yuan, representing a year-on-year increase of 73.64% [2][3] - The net profit attributable to shareholders reached approximately 62.32 million yuan, marking a significant year-on-year growth of 1006.99% [2][3] - The net profit after deducting non-recurring gains and losses was approximately 52.89 million yuan, a recovery from a loss of 605,600 yuan in the same period last year [2][3] - The net cash flow from operating activities was approximately 10.21 million yuan, compared to a negative cash flow of 4.31 million yuan in the previous year [3] Group 3: Historical Financial Data - Over the past five years, Zhenlei Technology's revenue has shown consistent growth, with figures of 152.1 million yuan, 190.6 million yuan, 242.6 million yuan, 280.8 million yuan, and 303.4 million yuan respectively [3] - The net profit attributable to shareholders over the same period has varied, with figures of 76.94 million yuan, 98.84 million yuan, 107.7 million yuan, 72.48 million yuan, and 17.85 million yuan [3] Group 4: Initial Public Offering (IPO) Details - Zhenlei Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 27, 2022, with an issue price of 61.88 yuan per share and a total issuance of 27.31 million shares [4] - The total funds raised from the IPO amounted to 1.69 billion yuan, with a net amount of 1.54 billion yuan after deducting issuance costs [4] Group 5: Stock Dividend and Bonus Issues - On May 26, 2023, the company announced a stock bonus plan of 4 additional shares for every 10 shares held, along with a pre-tax dividend of 3 yuan [5] - A similar plan was announced on May 9, 2024, proposing 4 additional shares for every 10 shares held and a pre-tax dividend of 1.7 yuan [6]

上海友升铝业股份有限公司 首次公开发行股票主板 上市公告书提示性公告 保荐人（主承销商）：国泰海通证券股份有限公司 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、 完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所（以下简称"上交所"）审核同意，上海友升铝业股份有 限公司（以下简称"友升股份""发行人"或"公司"）人民币普通股股票将于 2025 年 9 月 23 日在上交所主板上市，上市公告书全文和首次公开发行股票的招股 说明书全文披露于上交所网站（http://www.sse.com.cn）和符合中国证券监督管理 委 员 会规定条件 的 网 站 （ 中 国 证 券 网 ，www.cnstock.com；中证网， www.cs.com.cn；证券时报网，www.stcn.com；证券日报网，www.zqrb.cn；经济参 考网，网址 www.jjckb.cn），并置备于发行人、上交所、本次发行保荐人（主承 销商）国泰海通证券股份有限公司的住所，供投资者查阅。 一、上市概况 （五）首次公开发行股票数量：4,826.7111 万股，本次发行全部为新股，无 ...